Aldolase A Antibodies

Santa Cruz Biotechnology features a diverse variety of Aldolase A monoclonal antibodies for research focused on understanding this crucial enzyme. Aldolase A is a key glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate, playing a vital role in energy metabolism. Aldolase A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Aldolase A is particularly important in muscle and brain tissues, where it contributes to the regulation of glucose metabolism and energy production. Dysregulation of Aldolase A has been implicated in various metabolic disorders and cancers, making it a significant target for research. Investigating Aldolase A expression and activity patterns can reveal important insights into cellular metabolism and disease mechanisms. Research with Aldolase A monoclonal antibodies enables detailed analysis of metabolic pathways and their regulation. Santa Cruz Biotechnology monoclonal antibodies for Aldolase A support researchers worldwide in advancing our understanding of metabolic processes and potential therapeutic targets.